Nektar Therapeutics | NKTR - Trade Debtors


Nektar Therapeutics reported $1.78M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
ALKERMES USD 407.63M 73.6M Mar/2026
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Amgen USD 9.14B 432M Mar/2026
Baxter International USD 1.7B 310M Mar/2026
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
Biogen USD 1.79B 76.6M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cipla INR 62.19B 12.42B Mar/2026
Dr.Reddys Laboratories INR 104.74B 563M Mar/2026
Eisai JPY 227B 22.05B Mar/2026
Eli Lilly USD 21.18B 1.02B Mar/2026
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Exelixis USD 328.95M 42.03M Mar/2026
Gilead Sciences USD 4.74B 172M Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Grifols EUR 1B 285.88M Dec/2025
Halozyme Therapeutics USD 457.99M 16.72M Mar/2026
Incyte USD 1.05B 27.09M Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
MacroGenics USD 10.42M 2.95M Mar/2026
Merck USD 11.78B 345M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Neurocrine Biosciences USD 768.1M 81.3M Mar/2026
Novartis USD 9.6B 2.69B Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
Takeda JPY 876.35B 118.43B Mar/2026
Teva Pharmaceutical Industries USD 3.39B 316M Mar/2026
Xencor USD 12M 17.3M Mar/2026